Functional hallucinations in schizophrenia responding to adjunctive sodium valproate

Indian Journal of Psychological Medicine

Volumn 34, Issue 1, 2012, Pages 76-78

  Rajkumar, Ravi Philip ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hallucinations; risperidone; schizophrenia; sodium valproate

Indexed keywords

EID: 84861321908     PISSN: 02537176     EISSN: 09751564     Source Type: Journal    
DOI: 10.4103/0253-7176.96165     Document Type: Article

References (12)

1. Hamilton M, editor. Fish's Clinical Psychopathology. 2nd ed. Bristol: John Wright and Sons, Ltd.; 1985.
2. Pantelis C, Lambert TJ. Manging patients with " treatmentresistant" schizophrenia. MJA 2003;178:S62-6.
3. Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-92.
4. Suzuki T, Uchida H, Takeuchi H, Nakajima S, Nomura K, Tanabe A, et al. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia. Hum Psychopharmacol 2009;24:628-38.
5. Rathod S, Kingdon D, Weiden P, Turkington D. Cognitive behavioral therapy for medication-resistant schizophrenia: A review. J Psychiatr Pract 2008;14:22-33.
6. Kraft AM, Hassenfeld IN, Zarr M. Response of functional hallucinations to carbamazepine. Am J Psychiatry 1984;141:1018.
7. Bowden CL. Valproate. Bipolar Disord 2003;5:189-202.
8. Schwarz C, Volz A, Li C, Leucht S. Valproate for schizophrenia. Cochrane Database Syst Rev 2008;3:CD004028.
9. Yoshimura R, Shinkai K, Ueda N, Nakamura J. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients. Pharmacopsychiatry 2007;40:9-13.
10. Lopez LM, Wassef AA, Molloy MS, Williams NG. Valproic acid induces manifestations of simultaneous dopamine enhancement and reduction in schizophrenia. Neuropsychopharmacology 2004;29:1217.
11. Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, et al. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 2011;60:1007-16.
12. Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: Valproate, lamotrigine, carbamazepine and oxcarbazepine and actions at voltage-gated sodium channels. J Clin Psychiatry 2004;65:738-9.